Treatment with a 5-HT receptor 2c (5-HT2CR) antagonist significantly increases insulin secretion in islets of the db/db mice (Zhang et al., 2013), a model of type 2 diabetes (T2D). This evidence concerns the gene INS and type 2 diabetes mellitus.